ChiCTR2300071757 版本V1.1 版本创建时间2023/06/07 20:56:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300071757 

最近更新日期:

Date of Last Refreshed on:

2023-05-24 11:54:58 

注册时间:

Date of Registration:

2023-05-24 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

稳定期COPD患者无支撑上肢锻炼干预方案的构建及效果研究

Public title:

Construction and effectiveness of an intervention program for unsupported upper limb exercise in patients with stable COPD

注册题目简写:

English Acronym:

研究课题的正式科学名称:

稳定期COPD患者无支撑上肢锻炼干预方案的构建及效果研究

Scientific title:

Construction and effectiveness of an intervention program for unsupported upper limb exercise in patients with stable COPD

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

沈亮 

研究负责人:

沈亮 

Applicant:

Liang Shen 

Study leader:

Liang Shen 

申请注册联系人电话:

Applicant telephone:

+86 178 5731 2526

研究负责人电话:

Study leader's
telephone:

+86 178 5731 2526

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

247397030@qq.com

研究负责人电子邮件:

Study leader's E-mail:

247397030@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

杭州师范大学

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州师范大学仓前校区

研究负责人通讯地址:

浙江省杭州师范大学仓前校区

Applicant address:

Hangzhou Normal University

Study leader's address:

Hangzhou Normal University

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

杭州师范大学

Applicant's institution:

Hangzhou Normal University

研究负责人所在单位:

杭州师范大学

Affiliation of the Leader:

Hangzhou Normal University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

202313

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

杭州师范大学科学研究伦理委员会

Name of the ethic committee:

Hangzhou Normal University Scientific Research Ethics Committee

伦理委员会批准日期:

Date of approved by ethic committee:

2023-03-17 00:00:00

伦理委员会联系人:

汪胜

Contact Name of the ethic committee:

Wang Sheng

伦理委员会联系地址:

浙江省杭州市余杭区仓前街道余杭塘路2318号

Contact Address of the ethic committee:

No. 126, Wenzhou Road, Gongchen Bridge, Hangzhou, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 571 2886 1997

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

杭州师范大学

Primary sponsor:

Hangzhou Normal University

研究实施负责(组长)单位地址:

浙江省杭州市余杭区仓前街道余杭塘路2318号

Primary sponsor's address:

No. 126, Wenzhou Road, Gongchen Bridge, Hangzhou, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

杭州市

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州师范大学护理学院

具体地址:

浙江省杭州市余杭区仓前街道余杭塘路2318号

Institution
hospital:

School of Nursing, Hangzhou Normal University

Address:

No.2318, Yuhangtang Road, Cangqian Street, Yuhang District, Hangzhou, Zhejiang Province

经费或物资来源:

自费

Source(s) of funding:

Self-financed

研究疾病:

慢性阻塞性肺疾病  

Target disease:

COPD

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究基于文献回顾构建无支撑上肢锻炼方案,并验证无支撑上肢锻炼干预方案对COPD患者上肢活动能力、呼吸困难、生活质量的干预效果。  

Objectives of Study:

This study constructs an unsupported upper limb exercise program based on the literature review and validates the intervention effects of unsupported upper limb exercise program on upper limb mobility, dyspnea, and quality of life in COPD patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)符合慢性阻塞性肺疾病全球倡议制定的COPD相关诊断标准,按照肺功能分级要求符合中重度,即 30%≤FEV1%pred<80%;(2)没有接受过规范的上肢康复锻炼;(3)疾病处于稳定阶段:指患者咳嗽、喘息等症状轻微或无,静息状态下血氧饱和度≥88%且病人已获得出院许可证;(4)意识清楚,具有运动、沟通交流能力;(5)所有患者均知情同意并签署合作协议书。

Inclusion criteria

(1) conform to the COPD-related diagnostic criteria established by the Global Initiative for Chronic Obstructive Pulmonary Disease, and conform to moderate severity according to pulmonary function grading requirements, i.e., 30% ≤ FEV1%pred < 80%; (2) have not received standardized upper extremity rehabilitation exercises; (3) the disease is in a stable stage: meaning that the patient has mild or no symptoms such as coughing and wheezing, and the oxygen saturation at rest is ≥ 88% and the patient has obtained a discharge permit; (4) are conscious and have the ability to exercise and communicate; (5) all patients have given informed consent and signed the cooperation agreement.

排除标准:

(1)其它严重肺部疾病:包括肺癌、间质性肺炎、肺结核、气胸、肺血栓等;(2)合并严重的心脑血管疾病、严重的肝肾功能不全、骨质疏松、重症肌无力、妊娠及哺乳期妇女等;(3)有上肢运动障碍及其他相关禁忌症的患者。

Exclusion criteria:

(1) other serious lung diseases: including lung cancer, interstitial pneumonia, tuberculosis, pneumothorax, pulmonary thrombosis, etc.; (2) combined with serious cardiovascular and cerebrovascular diseases, severe hepatic and renal insufficiency, osteoporosis, myasthenia gravis, pregnancy and lactating women, etc.; (3) patients with upper limb movement disorders and other related contraindications.

研究实施时间:

Study execute time:

From 2023-05-25 00:00:00 To 2023-12-20 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-06-01 00:00:00 To 2023-09-30 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

22

Group:

Intervention group

Sample size:

干预措施:

无支撑上肢锻炼

干预措施代码:

Intervention:

unsupported upper limb exercise

Intervention code:

组别:

对照组

样本量:

22

Group:

control group

Sample size:

干预措施:

常规干预

干预措施代码:

Intervention:

Routine intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江省 

市(区县):

杭州市 

Country:

China

Province:

Zhejiang

City:

Hangzhou

单位(医院):

杭州拱宸桥街道社区卫生服务中心 

单位级别:

社区服务中心 

Institution
hospital:

Hangzhou Gongchenqiao Street Community Health Service Center

Level of the institution:

Community Health Service Center

测量指标:

Outcomes:

指标中文名:

呼吸困难程度

指标类型:

次要指标

Outcome:

Degree of dyspnea

Type:

Secondary indicator

测量时间点:

入组当天及入组12周后

测量方法:

mMRC量表

Measure time point of outcome:

Day of enrollment and 12 weeks after enrollment

Measure method:

mMRC scale

指标中文名:

上肢活动能力

指标类型:

主要指标

Outcome:

Upper Limb Mobility

Type:

Primary indicator

测量时间点:

入组当天及入组12周后

测量方法:

6min移圈试验

Measure time point of outcome:

Day of enrollment and 12 weeks after enrollment

Measure method:

6-min Pegboard and Ring Test

指标中文名:

生活质量

指标类型:

次要指标

Outcome:

Quality of life

Type:

Secondary indicator

测量时间点:

入组当天及入组12周后

测量方法:

CAT量表

Measure time point of outcome:

Day of enrollment and 12 weeks after enrollment

Measure method:

CAT scale

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 65 years
最大 Max age 80 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

在研究进行前,对社区服务中心内的所有服务站进行编号,由一名不参与资料收集与干预的研究者使用Excel生成随机数字对其进行赋值,规定随机数字为奇数的为干预站点,偶数为对照站点。

Randomization Procedure (please state who generates the random number sequence and by what method):

Before the study was conducted, all service stations within the community service centers were numbered and assigned a value by a researcher not involved in the data collection and intervention using Excel to generate random numbers, specifying that odd random numbers were the intervention stations and even num

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

研究采用单盲原则,为避免资料收集员在收集资料时出现主观偏倚,本研究对资料收集员实施单盲,不告知资料收集员研究对象的分组情况和具体干预内容。

Blinding:

The study was single-blinded, and to avoid subjective bias in data collection by the data collectors, the study was single-blinded to the data collectors, who were not informed of the grouping of the study subjects or the specific interventions.

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

none

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

none

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2023-05-24 11:54:34